These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26466780)

  • 1. Treating the whole body in Huntington's disease.
    Carroll JB; Bates GP; Steffan J; Saft C; Tabrizi SJ
    Lancet Neurol; 2015 Nov; 14(11):1135-42. PubMed ID: 26466780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease: from molecular pathogenesis to clinical treatment.
    Ross CA; Tabrizi SJ
    Lancet Neurol; 2011 Jan; 10(1):83-98. PubMed ID: 21163446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modifications as novel therapeutic targets for Huntington's disease.
    Wang F; Fischhaber PL; Guo C; Tang TS
    Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntingtin and its role in neuronal degeneration.
    Li SH; Li XJ
    Neuroscientist; 2004 Oct; 10(5):467-75. PubMed ID: 15359012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modifiers of Huntington's disease.
    Gusella JF; MacDonald ME; Lee JM
    Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering a disease-modifying treatment for Huntington's disease.
    Godinho BM; Malhotra M; O'Driscoll CM; Cryan JF
    Drug Discov Today; 2015 Jan; 20(1):50-64. PubMed ID: 25256777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: pathomechanism and therapeutic perspectives.
    Gárdián G; Vécsei L
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1485-94. PubMed ID: 15480847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington's Disease.
    Young D
    Methods Mol Biol; 2016; 1382():383-95. PubMed ID: 26611601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease: an update of therapeutic strategies.
    Kumar A; Kumar Singh S; Kumar V; Kumar D; Agarwal S; Rana MK
    Gene; 2015 Feb; 556(2):91-7. PubMed ID: 25447911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S; Kazantsev AG
    Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of neuronal death in Huntington's disease. First part: general considerations and histopathological features].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(5):413-21. PubMed ID: 18069515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology of Huntington's Disease.
    De Souza RA; Leavitt BR
    Curr Top Behav Neurosci; 2015; 22():81-100. PubMed ID: 25205327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.
    Martin B; Golden E; Keselman A; Stone M; Mattson MP; Egan JM; Maudsley S
    Histol Histopathol; 2008 Feb; 23(2):237-50. PubMed ID: 17999380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease.
    Shema R; Kulicke R; Cowley GS; Stein R; Root DE; Heiman M
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):268-72. PubMed ID: 25535386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Huntington's disease: cellular and molecular basis of pathology].
    Korzhova VV; Artamonov DN; Vlasova OL; Bezprozvannyĭ IB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(4):359-75. PubMed ID: 25723022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease.
    Ha AD; Fung VS
    Curr Opin Neurol; 2012 Aug; 25(4):491-8. PubMed ID: 22772878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
    Dowie MJ; Scotter EL; Molinari E; Glass M
    Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.